Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment…
Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization…
Read More...
Read More...
